Absence of a Pharmacokinetic Interaction between Losartan and Hydrochlorothiazide
- 1 December 1995
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 35 (12), 1200-1206
- https://doi.org/10.1002/j.1552-4604.1995.tb04047.x
Abstract
To support the use of a combination of losartan, a highly specific and selective AT1 angiotensin II receptor antagonist, and hydrochlorothiazide for treatment of hypertension, a pharmacokinetic drug interaction study was conducted. In this open-label, randomized, three-period, crossover study, patients with mild to moderate hypertension received a 12.5-mg tablet of hydrochlorothiazide, a 50-mg losartan tablet, or a combination tablet of 12.5 mg of hydrochlorothiazide and 50 mg of losartan for 7 days. Twelve patients (age range, 35–55 years; mean age, 44 years) were allocated to treatment. Drug interactions were evaluated by comparing the 24-hour area under the concentration-time curve (AUC24) for losartan and its active metabolite, E-3174, when losartan (50 mg) was given alone or in combination with 12.5 mg hydrochlorothiazide. The urinary recovery over the 24-hour period of hydrochlorothiazide was compared for hydrochlorothiazide (12.5 mg) given alone or in combination with 50 mg losartan. A clinically significant interaction was defined as a treatment difference of more than 35%. There was no evidence of a clinically significant effect of hydrochlorothiazide on the pharmacokinetics of losartan or E-3174, as the geometric mean AUC24 ratio (90% confidence interval [CI]) was 1.02 (0.95, 1.09) for losartan and 1.02 (0.96, 1.09) for E-3174. Based on urinary recovery over a 24-hour period of hydrochlorothiazide, losartan did not affect the pharmacokinetics of hydrochlorothiazide, as the geometric mean ratio of urinary hydrochlorothiazide recovery (90% CI) was 0.898 (0.79, 1.20). There was a minor (17%) decrease in the AUC24 of hydrochlorothiazide after administration of the combination tablet. Coadministration of hydrochlorothiazide and losartan was well tolerated.Keywords
This publication has 11 references indexed in Scilit:
- Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humansCancer Cell, 1995
- A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential HypertensionHypertension, 1995
- Fully automated methods for the determination of hydrochlorothiazide in human plasma and urineJournal of Pharmaceutical and Biomedical Analysis, 1994
- Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- The Statistical Evaluation of a Three-Period Two-Treatment Crossover Pharmacokinetic Drug Interaction StudyBiometrics, 1987
- Estimation of Variance for Harmonic Mean Half-LivesJournal of Pharmaceutical Sciences, 1985
- Pharmacokinetics of hydrochlorothiazide in manEuropean Journal of Clinical Pharmacology, 1977
- Absorption, metabolism, and excretion of hydrochlorothiazideCancer Cell, 1976